A clear look at 10 health conditions Canadians manage with medical cannabis, the real evidence behind each one, and how eligibility actually works in Canada.
Abstract: Hand spasticity and hypertonia are common in individuals who have sustained an upper motor neuron (UMN) injuries due to stroke and traumatic brain injury. While rehabilitation robots and ...
Generic medications are approved by the FDA because they have the same safety and effectiveness profiles as the name-brand or ...
3d
Dear Doctor: Heavy sensation in legs started at same time as new medication; what’s really to blame?
Leg heaviness after walking is a classic sign of poor circulation, but you have leg heaviness without doing exercise and also ...
Explore the challenges faced by families in Kerala caring for children with chronic disabilities and the urgent need for ...
Morning Overview on MSN
Weight-loss drugs like Ozempic may quietly leave your muscles weaker, a new study warns
Millions of people taking semaglutide or tirzepatide for weight loss could be losing more than fat. A pharmacovigilance study ...
Zimmer Biomet Holdings (NYSE:ZBH) agreed to acquire Pacira BioSciences’ FDA cleared iovera pain relief device. The agreement ...
The federal government has launched a new program to make GLP-1 weight loss drugs more affordable for older Americans.
The program, which will make weight loss drugs eligible for people on Medicare for $50 a month, is set to run for only 18 ...
Sarepta Therapeutics is seeking to convert the accelerated approval of its therapeutic exon-skippers for Duchenne muscular dystrophy to full despite the drugs’ failure to improve motor function in a ...
GLP-1 receptor agonists (GLP-1 RA) medications were shown to reduce the number of deaths, amputations and hospitalizations ...
If your doctor prescribes a GLP-1 medication for weight loss but your insurance won’t cover it, you have options.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results